Added to YB: 2026-06-01
Pitch date: 2026-05-28
GALE.SW [neutral]
Galenica AG
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Galenica AG provides healthcare services in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT.
Market Cap
CHF 4.1B
Pitch Price
N/A
Price Target
N/A
Dividend
3.03%
EV/EBITDA
15.42
P/E
22.57
EV/Sales
1.22
Sector
Health Care Providers and Services
Category
growth
Galenica (GALE Switzerland): pharmacy momentum offsets softer consumer health trends
GALE.SW (update): 4M26 sales CHF1.41bn +7% YoY, ahead of consensus. Pharmacy +7% (share gains), GLP-1 strong, Puravita boost; offset by Products & Brands -13% (Perskindol/Verfora soft). Diagnostics +CHF41m, Services & Production +9%. FY26 guide reaffirmed: 5-7% sales, 6-8% EBIT growth. Defensive valuation already reflects quality; growth partly M&A-driven.
Read full article (2 min)